Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> AVASTIN Latest News

OCT 17, 2014 - Reuters

A Must Read - Share

Regeneron's Eylea works better vs Avastin and Lucentis in study

(Reuters) - Regeneron Pharmaceuticals Inc said on Friday that a head-to-head study showed that its Eylea treatment for diabetic macular edema created significantly greater improvement in visual acuity compared with Genentech's Avastin and Lucentis.

Tags: Regeneron's Eylea works better vs Avastin and Lucentis in study,  Avastin Latest News